Otsuka Holdings
4578.T
#633
Rank
NZ$54.03 B
Marketcap
$100.31
Share price
-0.72%
Change (1 day)
65.37%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2024 (TTM): NZ$1.67 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are NZ$14.47 Billion. In 2023 the company made an earning of NZ$1.79 Billion a decrease over its 2022 earnings that were of NZ$2.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$1.67 B-6.94%
2023 NZ$1.79 B-20.82%
2022 NZ$2.26 B-13.04%
2021 NZ$2.60 B-19.69%
2020 NZ$3.24 B13.78%
2019 NZ$2.85 B52.13%
2018 NZ$1.87 B11.32%
2017 NZ$1.68 B-36.26%
2016 NZ$2.64 B31.64%
2015 NZ$2.00 B
2013 NZ$4.18 B33.73%
2012 NZ$3.12 B-4.78%
2011 NZ$3.28 B46.23%
2010 NZ$2.24 B